Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-26-117738
Filing Date
2026-03-20
Accepted
2026-03-20 16:30:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d206837d424b3.htm 424B3 149202
2 GRAPHIC g206837g12p03.jpg GRAPHIC 58443
  Complete submission text file 0001193125-26-117738.txt   230864
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-294315 | Film No.: 26778613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)